Pre-exposure prophylaxis (PrEP) is an HIV medicine taken by people who do not have HIV that reduces the risk of getting HIV from sex by about 99% and from injection drug use by at least 74%.
Although PrEP protects against HIV during sex without a condom or if a condom fails, it does not protect against other sexually transmitted infections (STIs) an
To prevent perinatal transmission of HIV after childbirth, HIV medicines should be continued postpartum and should also be started for infants exposed to HIV at birth, ideally within six hours of delivery.
HIV testing is recommended for all infants who may be exposed to HIV during pregnancy or childbirth; more frequent testing is recommended for infants at
HIV medicines (known as antiretrovirals) should be started as soon as possible during pregnancy and/or continued throughout pregnancy to maintain good health, prevent perinatal transmission of HIV, and prevent HIV transmission to sexual partners.
Because most HIV medicines are considered safe during pregnancy,
When available, a preventive HIV vaccine will be given to people who do not have HIV, with the goal of preventing HIV infection if they are exposed to the virus.
An investigational drug, also called an experimental drug, is a drug that is being studied to see whether it is safe and effective and how much of the drug is needed to treat a disease or medical condition.
Investigational HIV drugs are studied in medical research studies called clinical trial
A latent HIV reservoir is a group of CD4 T lymphocytes (CD4 cells) in the body that are infected with HIV but are not actively producing new HIV virus particles.
Finding ways to target and either destroy or silence latent reservoirs is a major challenge facing HIV researchers who are exploring different strategies for curing HIV inf